FDA approves a cholesterol pill unlike anything before
The Food and Drug Administration has approved Lipfendra, the first oral PCSK9 inhibitor for treating high cholesterol, including a genetic form known as familial hypercholesterolemia. Manufactured by Merck, the once daily pill offers patients an alternative to the injectable versions of this drug class that have been available for years, and it is expected to […]
Ozempic’s New Pill Form Could Change Who Has Access
Novo Nordisk has begun selling an oral version of semaglutide in the United States under the Ozempic name, a move that extends one of the most recognized drug brands in recent memory into a format that does not require an injection. The pill became available on May 4, 2026, at more than 70,000 pharmacies nationwide, […]